Resolve Therapeutics
Focus: Resolve Therapeutics is a public biotechnology company headquartered in Miami focused on biologics development across cardiovascular, immunology, and infectious disease indications. The company maintains a lean pipeline centered on its lead program RSLV-132 in autoimmune conditions.
Profile data last refreshed 3h ago · AI intelligence enriched 8h ago
Funding Stage
PUBLIC
Open Jobs
1
Should You Work at Resolve Therapeutics?
AI assessmentResolve is a speculative early-stage play suitable for scientists willing to bet on RSLV-132's clinical momentum, but the tight hiring freeze and absent Phase 3 catalysts limit career security.
Why Work Here
- Lead asset RSLV-132 spans multiple Phase 2 trials in high-unmet-need autoimmune indications (SLE, Sjögren's, Long COVID), offering exposure to immunology development
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
12 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Build capacity of canteen
Food SelectionClinical Trials (1)
NCT05664256Evaluation of a Healthy Food Procurement Policy at Municipality-level in Nepal
N/AHelp build intelligence for Resolve Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.